Non-animal models of epithelial barriers (skin, intestine and lung) in research, industrial applications and regulatory toxicology
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Models of the outer epithelia of the human body - namely the skin, the intestine and the lung - have found valid applications in both research and industrial settings as attractive alternatives to animal testing. A variety of approaches to model these barriers are currently employed in such fields, ranging from the utilization of ex vivo tissue to reconstructed in vitro models, and further to chip-based technologies, synthetic membrane systems and, of increasing current interest, in silico modeling approaches. An international group of experts in the field of epithelial barriers was convened from academia, industry and regulatory bodies to present both the current state of the art of non-animal models of the skin, intestinal and pulmonary barriers in their various fields of application, and to discuss research-based, industry-driven and regulatory-relevant future directions for both the development of new models and the refinement of existing test methods. Issues of model relevance and preference, validation and standardization, acceptance, and the need for simplicity versus complexity were focal themes of the discussions. The outcomes of workshop presentations and discussions, in relation to both current status and future directions in the utilization and development of epithelial barrier models, are presented by the attending experts in the current report.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche
Sato, T., Vries, R. G., Snippert, H. J., van de Wetering, M., Barker, N., Stange, D. E., van Es, J. H., Abo, A., Kujala, P., Peters, P. J., et al. (2009) · Nature · doi:10.1038/nature07935 · Cited by 7,204 · cited 3×
“Recently, based on the three-dimensional organoid protocols described above, several groups have independently published descriptions of methods by which leucine-rich repeat-containing G protein-coupled receptor 5 (LGR-5)- or Ephrin type-B receptor 2 (EphB2)-positive intestinal stem cells can be isolated from primary…”
BackgroundAmidon, G. L., Lennernäs, H., Shah, V. P., & Crison, J. R. (1995) · Pharmaceutical Research · doi:10.1023/a:1016212804288 · Cited by 5,430 · cited 4×
“Optimizing permeability in contrast to receptor affinity according to “Lipinski’s rule of five” (Lipinski et al., 1997) has become a well-accepted new paradigm in drug discovery for medicinal chemists; such in vitro approaches are also widely used in pharma for the approval of generics, in conjunction with the BCS as…”
MethodInfluentialRole of the microbiota in immunity and inflammation.
Belkaid, Y., & Hand, T. W. (2014) · Cell · doi:10.1016/j.cell.2014.03.011 · Cited by 5,385
Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation
Arpaia, N., Campbell, C., Fan, X., Dikiy, S., van der Veeken, J., deRoos, P., Liu, H., Cross, J. R., Pfeffer, K., Coffer, P. J., et al. (2013) · Nature · doi:10.1038/nature12726 · Cited by 4,838 · cited 2×
“Carrier-driven translocation of trans- and behavior (Arpaia et al., 2013; Foster and McVey Neufeld, 2013; Hsiao et al., 2013; Possemiers et al., 2009; Tralau et al., 2014).”
Reconstituting organ-level lung functions on a chip
Huh, D., Matthews, B. D., Mammoto, A., Montoya-Zavala, M., Hsin, H. Y., & Ingber, D. E. (2010) · Science · doi:10.1126/science.1188302 · Cited by 4,250 · cited 2×
“…investigations into the expression and functionality of enzymes involved in cutaneous biotransformation of xenobiotics in human skin ex vivo as well as in reconstructed tissue models are ongoing, and knowledge continues to improve (Gotz et al., 2012; Huh et al., 2010; Oesch et al., 2014).”
BackgroundHsiao, E. Y., McBride, S. W., Hsien, S., Sharon, G., Hyde, E. R., McCue, T., Codelli, J. A., Chow, J., Reisman, S. E., Petrosino, J. F., et al. (2013) · Cell · doi:10.1016/j.cell.2013.11.024 · Cited by 3,283
Gut–brain axis: How the microbiome influences anxiety and depression
Foster, J. A., & McVey Neufeld, K.-A. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2013.01.005 · Cited by 2,460
Hidalgo, I. J., Raub, T. J., & Borchardt, R. T. (1989) · Gastroenterology · doi:10.1016/s0016-5085(89)80072-1 · Cited by 2,396
Kim, H. J., Huh, D., Hamilton, G., & Ingber, D. E. (2012) · Lab on a Chip · doi:10.1039/c2lc40074j · Cited by 1,734
Kansy, M., Senner, F., & Gubernator, K. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm970530e · Cited by 1,304 · cited 21×
“Additionally, PAMPA filters may become blocked, leading to inaccurate permeability data (Avdeef et al., 2001; Hamalainen and Frostell-Karlsson, 2004; Seo et al., 2006).”
MethodInfluentialSustained in vitro intestinal epithelial culture within a Wnt-dependent stem cell niche
Ootani, A., Li, X., Sangiorgi, E., Ho, Q. T., Ueno, H., Toda, S., Sugihara, H., Fujimoto, K., Weissman, I. L., Capecchi, M. R., et al. (2009) · Nature Medicine · doi:10.1038/nm.1951 · Cited by 906
Maschmeyer, I., Lorenz, A. K., Schimek, K., Hasenberg, T., Ramme, A. P., Hübner, J., Lindner, M., Drewell, C., Bauer, S., Thomas, A., et al. (2015) · Lab on a Chip · doi:10.1039/c5lc00392j · Cited by 861
The use of 3-d cultures for high-throughput screening: the multicellular spheroid model.
Kunz-Schughart, L. A., Freyer, J. P., Hofstaedter, F., & Ebner, R. (2004) · SLAS DISCOVERY · doi:10.1177/1087057104265040 · Cited by 797 · cited 1×
“…used for studying processes involved in morphogenesis and branching (Hayden, 2012; Hubatsch et al., 2007) and may also offer pharmaceutical companies potential for high throughput screening using approaches similar to those employed for evaluating anti-cancer drugs (Kunz-Schughart et al., 2004).”
MethodAlveolar epithelial type II cell: defender of the alveolus revisited
Fehrenbach, H. (2001) · Respiratory Research · doi:10.1186/rr36 · Cited by 757 · cited 23×
“Under appropriate culture conditions, the ATII cells differentiate into an ATI-like phenotype within approximately one week, achieving TEER values of ~2,000-2,500 Ω cm2 suitable for transport studies (Daum et al., 2012; Elbert et al., 1999) and showing an increase in caveolin-1 positive, Sp-C negative cells (Fuchs et…”
BackgroundInfluentialGut-on-a-Chip microenvironment induces human intestinal cells to undergo villus differentiation
Kim, H. J., & Ingber, D. E. (2013) · Integrative Biology · doi:10.1039/c3ib40126j · Cited by 750 · cited 1×
“Additionally, a “Gut-ona-Chip” has been recently developed using Caco-2 cells (Kim and Ingber, 2013).”
MethodRedundant sources of Wnt regulate intestinal stem cells and promote formation of Paneth cells
Farin, H. F., Van Es, J. H., & Clevers, H. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.08.031 · Cited by 655 · cited 2×
“In this respect, mouse and human intestinal crypts are embedded in a three dimensional matrix such as Matrigel or Collagen I covered with medium basically mimicking the intestinal stem cell niche by providing factors of the Wnt-, EGF-, BMP-, and Notch-signaling pathways (Cao et al., 2013; Farin et al., 2012).”
BackgroundThe important role of stratum corneum lipids for the cutaneous barrier function
van Smeden, J., Janssens, M., Gooris, G. S., & Bouwstra, J. A. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.11.006 · Cited by 549
Self-citationOh, J. Z., Ravindran, R., Chassaing, B., Carvalho, F. A., Maddur, M. S., Bower, M., Hakimpour, P., Gill, K. P., Nakaya, H. I., Yarovinsky, F., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.08.009 · Cited by 541
Matrix stiffness-induced myofibroblast differentiation is mediated by intrinsic mechanotransduction
Huang, X., Yang, N., Fiore, V. F., Barker, T. H., Sun, Y., Morris, S. W., Ding, Q., Thannickal, V. J., & Zhou, Y. (2012) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2012-0050oc · Cited by 530
Schmook, F. P., Meingassner, J. G., & Billich, A. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00665-7 · Cited by 529
Wagner, I., Materne, E.-M., Brincker, S., Süßbier, U., Frädrich, C., Busek, M., Sonntag, F., Sakharov, D. A., Trushkin, E. V., Tonevitsky, A. G., et al. (2013) · Lab on a Chip · doi:10.1039/c3lc50234a · Cited by 476
A Modular Approach to the ECVAM Principles on Test Validity
Hartung, T., Bremer, S., Casati, S., Coecke, S., Corvi, R., Fortaner, S., Gribaldo, L., Halder, M., Hoffmann, S., Roi, A. J., et al. (2004) · Alternatives to Laboratory Animals · doi:10.1177/026119290403200503 · Cited by 341 · cited 2×
“Therefore, several national and international institutions like EURL ECVAM in the EU, the US validation body, the National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM) and the Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM)…”
BackgroundMethodSelf-citationWeerheim, A., & Ponec, M. (2001) · Archives of Dermatological Research · doi:10.1007/s004030100212 · Cited by 302 · cited 1×
“Being significantly different from other biobarriers, the lipid matrix of the stratum corneum contains ceramides, free fatty acids and cholesterol in an approximately equimolar ratio (van Smeden et al., 2014; Weerheim and Ponec, 2001).”
BackgroundRosdy, M., & Clauss, L.-C. (1990) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12555510 · Cited by 280
PAMPA—critical factors for better predictions of absorption
Avdeef, A., Bendels, S., Di, L. I., Faller, B., Kansy, M., Sugano, K., & Yamauchi, Y. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21068 · Cited by 240
Prediction of skin permeation by chemical compounds using the artificial membrane, Strat-M™
Uchida, T., Kadhum, W. R., Kanai, S., Todo, H., Oshizaka, T., & Sugibayashi, K. (2015) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2014.11.002 · Cited by 230
Krishna, M., Madden, J., Teran, L., Biscione, G., Lau, L., Withers, N., Sandstrom, T., Mudway, I., Kelly, F., Walls, A., et al. (1998) · European Respiratory Journal · doi:10.1183/09031936.98.11061294 · Cited by 107 · cited 2×
“For ethical reasons, studies in humans are restricted to some baseline investigations and a limited range of in vivo challenges (e.g., allergen, ozone, exercise, diesel exhaust) used in conjunction with morphological assessment of tissue biopsies or cells obtained by bronchoalveolar lavage (BAL) (Krishna et al., 1998;…”
MethodValidation and quality control of replacement alternatives - current status and future challenges
Leist, M., Hasiwa, N., Daneshian, M., & Hartung, T. (2012) · Toxicology Research · doi:10.1039/c2tx20011b · Cited by 100 · cited 2×
“Therefore, several national and international institutions like EURL ECVAM in the EU, the US validation body, the National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM) and the Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM)…”
BackgroundMethodSelf-citationDegradation of benzo[a]pyrene by bacterial isolates from human skin
Sowada, J., Schmalenberger, A., Ebner, I., Luch, A., & Tralau, T. (2014) · FEMS Microbiology Ecology · doi:10.1111/1574-6941.12276 · Cited by 77 · cited 1×
“A recent proof of principle study showed the formation of cytotoxic and carcinogenic metabolites from benzo[a]pyrene (B[a]P) by common skin commensals (Sowada et al., 2014; T. Tralau, personal communication).”
BackgroundHeikkinen, A. T., Baneyx, G., Caruso, A., & Parrott, N. (2012) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.06.013 · Cited by 76 · cited 2×
“com/) utilized by a number of top pharmaceutical companies as well as various independent researchers (Heikkinen et al., 2012; Saxena et al., 2015).”
BackgroundInvolvement of Creatine Kinase B in Cigarette Smoke–Induced Bronchial Epithelial Cell Senescence
Hara, H., Araya, J., Takasaka, N., Fujii, S., Kojima, J., Yumino, Y., Shimizu, K., Ishikawa, T., Numata, T., Kawaishi, M., et al. (2012) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2011-0214oc · Cited by 50
Cited by
Marx, U. (2016) · ALTEX · doi:10.14573/altex.1603161 · Cited by 295
“Three-dimensional skin models, such as MatTek’s EpidermTM, Henkel’s Phenion® and SkinEthic’s EpiskinTM, have proven to be valuable tools for toxicity testing and have been extensively reviewed in a recent t4 report (Gordon et al., 2015).”
InfluentialAir-Liquid interface cultures to model drug delivery through the mucociliary epithelial barrier
Lee, R. E., Reidel, B., Nelson, M. R., Macdonald, J. K., Kesimer, M., & Randell, S. H. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114866 · Cited by 71
Ainslie, G. R., Davis, M., Ewart, L., Lieberman, L. A., Rowlands, D. J., Thorley, A. J., Yoder, G., & Ryan, A. M. (2019) · Lab on a Chip · doi:10.1039/c9lc00492k · Cited by 65
Bas, A., Burns, N., Gulotta, A., Junker, J., Drasler, B., Lehner, R., Aicher, L., Constant, S., Petri‐Fink, A., & Rothen‐Rutishauser, B. (2021) · Small · doi:10.1002/smll.202006027 · Cited by 60
Mieremet, A., Vázquez García, A., Boiten, W., van Dijk, R., Gooris, G., Bouwstra, J. A., & El Ghalbzouri, A. (2019) · Scientific Reports · doi:10.1038/s41598-019-44204-4 · Cited by 42
Metadata
- Authors
- Gordon, S.
- Venue
- ALTEX
- Publisher
- ALTEX Edition
- Published
- 2015
- Volume
- 32
- Issue
- 4
- Pages
- 327-378
- ISSN
- 0946-7785 (ISSN-L)
- 1868-596X
- OpenAlex
- W2182798702
- Cited by
- 144
- References
- 31
- FWCI
- 20.82
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.